Hydroxyurea Exposure in Lactation: a Pharmacokinetics Study (HELPS)
The Journal of Pediatrics(2020)
摘要
Lactation is contraindicated for women with sickle cell anemia receiving hydroxyurea therapy, despite sparse pharmacokinetics data. In 16 women who were lactating volunteers, we documented hydroxyurea transferred into breastmilk with a relative infant dosage of 3.4%, which is below the recommended 5%-10% safety threshold. Breastfeeding should be permitted for women taking daily oral hydroxyurea.
更多查看译文
关键词
hydroxyurea,sickle cell anemia,breastfeeding,pharmacokinetics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要